ArticleRheumatology advances in practice2026
Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment.
Kimberly Loh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.